Financial Year |
June 30 2021 |
Monetary Funds |
19,428,081,027.23 |
Held-for-trading Financial Assets |
-- |
Notes Receivable |
1,503,258,711.46 |
Accounts Receivable |
13,457,652,023.17 |
Advances to Suppliers |
7,851,622,839.93 |
Other Receivables |
11,929,984,475.06 |
Amounts Due From Related Companies |
-- |
Interest Receivable |
-- |
Dividend Receivable |
-- |
Inventories |
52,554,953,988.61 |
Among: Consumptive Biological Assets |
-- |
Non-Current Assets Maturing Within One Year |
1,042,688,238.87 |
Other Current Assets |
4,559,700,570.53 |
Total Current Assets |
144,778,419,730.40 |
Available-for-Sale Financial Asset |
-- |
Held-to-maturity Investments |
-- |
Long-Term Account Receivable |
10,502,102,236.16 |
Long-term Equity Investment |
30,870,122,869.04 |
Investment Properties |
180,482,322.50 |
Fixed Assetes |
17,875,134,254.70 |
Under-construction Projects |
1,642,228,452.11 |
Construction Materials |
-- |
Disposal of Fixed Assets |
-- |
Capitalized Biological Assets |
-- |
Oil and Gas Assets |
-- |
Intangible Assets |
42,524,443,943.66 |
R&D expenses |
58,639,301.08 |
Goodwill |
1,895,833,717.83 |
Long-Term Deferred and Prepaid Expenses |
454,449,515.51 |
Deferred Income Tax Assets |
1,079,258,641.20 |
Other Non-Current Assets |
9,829,518,729.02 |
Sub-Total of Non-Current Assets |
125,020,642,849.49 |
Total Assets |
269,799,062,579.89 |
Short-Term Loans |
19,383,389,988.83 |
Trading Financial liabilities |
-- |
Notes Payable |
3,479,462,948.07 |
Accounts Payable |
43,739,679,623.70 |
Accounts Received In Advance |
-- |
Employee Compensation Payable |
352,785,652.30 |
Taxes Payable |
4,045,371,753.33 |
Interest Payable |
737,702,683.79 |
Dividend Payable |
853,501,028.34 |
Other payables |
19,976,623,660.58 |
Due to Related Companies |
-- |
Non-Current Liabilities Due Within One Year |
4,139,796,157.19 |
Other Current Liabilities |
983,314,510.52 |
Sub-Total of Current Liabilities |
120,442,700,320.74 |
Long-term Loans |
48,040,042,061.07 |
Bonds Payable |
10,000,000,000.00 |
Long-Term Accounts Payable |
48,374,909.08 |
Special Payable |
-- |
Estimatied Liabilities |
41,288,262.79 |
Deferred Income Tax Liabilities |
1,301,704,702.87 |
Other Non-Current Liabilities |
153,379,192.91 |
Sub-Total of Non-Current Liabilities |
62,128,637,535.27 |
Total Liabilities |
182,571,337,856.01 |
Paid-In Capital(Or Share Stock) |
4,604,777,412.00 |
Capital Surplus |
7,730,330,997.55 |
Surplus Reserve |
2,403,221,827.56 |
LESS:Treasury Stock |
-- |
Undistributed Profits |
19,718,470,012.83 |
Minority Stockholder's Interest |
16,378,029,585.30 |
Foreign Currency Capital |
-- |
Abnormal Management Project Income Adjusted |
-- |
Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
70,849,695,138.58 |
Owner's Equity(Stockholder's Equity) |
87,227,724,723.88 |
Total Liabilities and Owner's Equity(Stockholder's Equity) |
269,799,062,579.89 |